Melodie A Armstrong, MD | |
8550 Marshall Dr, Lenexa, KS 66214-1505 | |
(913) 495-2000 | |
Not Available |
Full Name | Melodie A Armstrong |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 8550 Marshall Dr, Lenexa, Kansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093821779 | NPI | - | NPPES |
100176430E | Medicaid | KS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 21817 (New Hampshire) | Secondary |
207Q00000X | Family Medicine | 0425079 (Kansas) | Primary |
Entity Name | Dartmouth-hitchcock Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
The role of microglial cells in neurodegenerative disease is not fully understood. But new results from researchers in Munich and Basel suggest that stimulation of this arm of the immune system might well delay the onset of such disorders.
Scientists at Cold Spring Harbor Laboratory and Stanford University have pinpointed the circuit in the brain that is responsible for sleepless nights in times of stress-and it turns out that circuit does more than make you toss and turn.
Prepare to hear a lot about Medicaid, the government health-insurance program for the poor. ... The U.S. government can't put itself on a sustainable fiscal course without doing something to slow health spending. It can't slow health spending costs without treating Medicaid. And it can't treat Medicaid without confronting the fact that it has become the long-term-care insurer of last resort for an aging society.
Researchers today presented results from the Phase III DEFINE (Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib) study with Merck's investigational CETP inhibitor, anacetrapib. In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, anacetrapib showed no significant differences from placebo in the primary safety measures studied.
A new study posted to the medRxiv* preprint server, analyzed safety data from over 298 million mRNA COVID-19 vaccines administered in the first six months after the U.S. began its vaccination campaign.
› Verified 9 days ago
Entity Name | Indian Stream Health Center, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386673952 PECOS PAC ID: 4789621921 Enrollment ID: O20051209000107 |
News Archive
The role of microglial cells in neurodegenerative disease is not fully understood. But new results from researchers in Munich and Basel suggest that stimulation of this arm of the immune system might well delay the onset of such disorders.
Scientists at Cold Spring Harbor Laboratory and Stanford University have pinpointed the circuit in the brain that is responsible for sleepless nights in times of stress-and it turns out that circuit does more than make you toss and turn.
Prepare to hear a lot about Medicaid, the government health-insurance program for the poor. ... The U.S. government can't put itself on a sustainable fiscal course without doing something to slow health spending. It can't slow health spending costs without treating Medicaid. And it can't treat Medicaid without confronting the fact that it has become the long-term-care insurer of last resort for an aging society.
Researchers today presented results from the Phase III DEFINE (Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib) study with Merck's investigational CETP inhibitor, anacetrapib. In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, anacetrapib showed no significant differences from placebo in the primary safety measures studied.
A new study posted to the medRxiv* preprint server, analyzed safety data from over 298 million mRNA COVID-19 vaccines administered in the first six months after the U.S. began its vaccination campaign.
› Verified 9 days ago
Entity Name | Alliance Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891859419 PECOS PAC ID: 8022019215 Enrollment ID: O20070131000394 |
News Archive
The role of microglial cells in neurodegenerative disease is not fully understood. But new results from researchers in Munich and Basel suggest that stimulation of this arm of the immune system might well delay the onset of such disorders.
Scientists at Cold Spring Harbor Laboratory and Stanford University have pinpointed the circuit in the brain that is responsible for sleepless nights in times of stress-and it turns out that circuit does more than make you toss and turn.
Prepare to hear a lot about Medicaid, the government health-insurance program for the poor. ... The U.S. government can't put itself on a sustainable fiscal course without doing something to slow health spending. It can't slow health spending costs without treating Medicaid. And it can't treat Medicaid without confronting the fact that it has become the long-term-care insurer of last resort for an aging society.
Researchers today presented results from the Phase III DEFINE (Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib) study with Merck's investigational CETP inhibitor, anacetrapib. In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, anacetrapib showed no significant differences from placebo in the primary safety measures studied.
A new study posted to the medRxiv* preprint server, analyzed safety data from over 298 million mRNA COVID-19 vaccines administered in the first six months after the U.S. began its vaccination campaign.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Melodie A Armstrong, MD 8550 Marshall Dr, Lenexa, KS 66214-1505 Ph: () - | Melodie A Armstrong, MD 8550 Marshall Dr, Lenexa, KS 66214-1505 Ph: (913) 495-2000 |
News Archive
The role of microglial cells in neurodegenerative disease is not fully understood. But new results from researchers in Munich and Basel suggest that stimulation of this arm of the immune system might well delay the onset of such disorders.
Scientists at Cold Spring Harbor Laboratory and Stanford University have pinpointed the circuit in the brain that is responsible for sleepless nights in times of stress-and it turns out that circuit does more than make you toss and turn.
Prepare to hear a lot about Medicaid, the government health-insurance program for the poor. ... The U.S. government can't put itself on a sustainable fiscal course without doing something to slow health spending. It can't slow health spending costs without treating Medicaid. And it can't treat Medicaid without confronting the fact that it has become the long-term-care insurer of last resort for an aging society.
Researchers today presented results from the Phase III DEFINE (Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib) study with Merck's investigational CETP inhibitor, anacetrapib. In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, anacetrapib showed no significant differences from placebo in the primary safety measures studied.
A new study posted to the medRxiv* preprint server, analyzed safety data from over 298 million mRNA COVID-19 vaccines administered in the first six months after the U.S. began its vaccination campaign.
› Verified 9 days ago
Dr. Nida Dillon, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12210 W 87th Street Pkwy, Lenexa, KS 66215 Phone: 913-438-6700 Fax: 913-338-1311 | |
Matthew Almaguer, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9040 Quivira Rd, Lenexa, KS 66215 Phone: 913-888-1151 Fax: 913-888-1822 | |
Dr. Jeremy Bruce Kirchoff, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12210 W 87th Street Pkwy, Lenexa, KS 66215 Phone: 913-438-6700 Fax: 913-338-1311 | |
Dr. Craig W Brown, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9040 Quivira Rd, Lenexa, KS 66215 Phone: 913-888-1151 | |
Paula L Nauer, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8550 Marshall Dr, Suite 200, Lenexa, KS 66214 Phone: 913-495-2000 Fax: 913-495-3715 | |
Dr. Angelique' C Pritchett, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12210 W 87th Street Pkwy, Suite 135, Lenexa, KS 66215 Phone: 913-438-6700 Fax: 913-428-1500 |